共 5 条
- [1] Co-targeting of the V2 receptor with tolvaptan and the natriuretic peptide A-receptor with B-type natriuretic peptide enhances water and sodium excretion without adversely affecting renal function: A novel physiologic approach to sodium and water retention in experimental heart failure JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S84 - S85
- [2] Coadministration of the v2 receptor antagonist tolvaptan and B-Type natriuretic peptide enhances water and sodium excretion without adversely affecting renal function: A Physiologic approach to sodium and water retention in experimental heart failure JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 297A - 297A